Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Anna Bauer-Mehren"'
Publikováno v:
Communications Medicine, Vol 1, Iss 1, Pp 1-10 (2021)
Plain language summary The clinical course of patients with COVID-19 is highly variable, with some patients barely affected and others dying. We wanted to better understand why this is the case and identify markers of COVID-19-associated mortality. T
Externí odkaz:
https://doaj.org/article/c84131697e1b4219b64e04fd36f36dbc
Publikováno v:
Frontiers in Artificial Intelligence, Vol 4 (2021)
Introduction: Prognostic scores are important tools in oncology to facilitate clinical decision-making based on patient characteristics. To date, classic survival analysis using Cox proportional hazards regression has been employed in the development
Externí odkaz:
https://doaj.org/article/3ea2c78de72443beaf43f1a7491a01e8
Autor:
Nigam H Shah, Paea LePendu, Anna Bauer-Mehren, Yohannes T Ghebremariam, Srinivasan V Iyer, Jake Marcus, Kevin T Nead, John P Cooke, Nicholas J Leeper
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0124653 (2015)
Proton pump inhibitors (PPIs) have been associated with adverse clinical outcomes amongst clopidogrel users after an acute coronary syndrome. Recent pre-clinical results suggest that this risk might extend to subjects without any prior history of car
Externí odkaz:
https://doaj.org/article/923e17b835b24e8c8decee77b1578c3d
Autor:
Nicholas J Leeper, Anna Bauer-Mehren, Srinivasan V Iyer, Paea Lependu, Cliff Olson, Nigam H Shah
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63499 (2013)
BackgroundPeripheral arterial disease (PAD) is a growing problem with few available therapies. Cilostazol is the only FDA-approved medication with a class I indication for intermittent claudication, but carries a black box warning due to concerns for
Externí odkaz:
https://doaj.org/article/c71709a69fe1404caaa92460471a83d8
Autor:
Pedro Lopes, Tiago Nunes, David Campos, Laura Ines Furlong, Anna Bauer-Mehren, Ferran Sanz, Maria Carmen Carrascosa, Jordi Mestres, Jan Kors, Bharat Singh, Erik van Mulligen, Johan Van der Lei, Gayo Diallo, Paul Avillach, Ernst Ahlberg, Scott Boyer, Carlos Diaz, José Luís Oliveira
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83016 (2013)
Pharmacovigilance plays a key role in the healthcare domain through the assessment, monitoring and discovery of interactions amongst drugs and their effects in the human organism. However, technological advances in this field have been slowing down o
Externí odkaz:
https://doaj.org/article/b8d3c88ad84a4bb2a59476df4ccc6583
Autor:
Preciosa M. Coloma, Martijn J. Schuemie, Gianluca Trifirò, Laura Furlong, Erik van Mulligen, Anna Bauer-Mehren, Paul Avillach, Jan Kors, Ferran Sanz, Jordi Mestres, José Luis Oliveira, Scott Boyer, Ernst Ahlberg Helgee, Mariam Molokhia, Justin Matthews, David Prieto-Merino, Rosa Gini, Ron Herings, Giampiero Mazzaglia, Gino Picelli, Lorenza Scotti, Lars Pedersen, Johan van der Lei, Miriam Sturkenboom
Publikováno v:
PLoS ONE, Vol 8, Iss 9 (2013)
Externí odkaz:
https://doaj.org/article/f9921eb8a9cf4ee7bbb4d588eb2203b9
Autor:
Preciosa M Coloma, Martijn J Schuemie, Gianluca Trifirò, Laura Furlong, Erik van Mulligen, Anna Bauer-Mehren, Paul Avillach, Jan Kors, Ferran Sanz, Jordi Mestres, José Luis Oliveira, Scott Boyer, Ernst Ahlberg Helgee, Mariam Molokhia, Justin Matthews, David Prieto-Merino, Rosa Gini, Ron Herings, Giampiero Mazzaglia, Gino Picelli, Lorenza Scotti, Lars Pedersen, Johan van der Lei, Miriam Sturkenboom, EU-ADR consortium
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72148 (2013)
Drug-related adverse events remain an important cause of morbidity and mortality and impose huge burden on healthcare costs. Routinely collected electronic healthcare data give a good snapshot of how drugs are being used in 'real-world' settings.To d
Externí odkaz:
https://doaj.org/article/f948e708d96c41b9866330706188815c
Autor:
Anna Bauer-Mehren, Erik M. van Mullingen, Paul Avillach, María del Carmen Carrascosa, Ricard Garcia-Serna, Janet Piñero, Bharat Singh, Pedro Lopes, José L. Oliveira, Gayo Diallo, Ernst Ahlberg Helgee, Scott Boyer, Jordi Mestres, Ferran Sanz, Jan A. Kors, Laura I. Furlong
Publikováno v:
PLoS Computational Biology, Vol 8, Iss 5 (2012)
Externí odkaz:
https://doaj.org/article/1767335860aa4cd2bddae68741aca6ae
Autor:
Anna Bauer-Mehren, Erik M van Mullingen, Paul Avillach, María Del Carmen Carrascosa, Ricard Garcia-Serna, Janet Piñero, Bharat Singh, Pedro Lopes, José L Oliveira, Gayo Diallo, Ernst Ahlberg Helgee, Scott Boyer, Jordi Mestres, Ferran Sanz, Jan A Kors, Laura I Furlong
Publikováno v:
PLoS Computational Biology, Vol 8, Iss 4, p e1002457 (2012)
Drug safety issues pose serious health threats to the population and constitute a major cause of mortality worldwide. Due to the prominent implications to both public health and the pharmaceutical industry, it is of great importance to unravel the mo
Externí odkaz:
https://doaj.org/article/6aef5971954d4f0a87e9cc952554fe7b
Autor:
Anna Bauer-Mehren, Markus Bundschus, Michael Rautschka, Miguel A Mayer, Ferran Sanz, Laura I Furlong
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20284 (2011)
BackgroundScientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the dise
Externí odkaz:
https://doaj.org/article/3f3946d1b8164922b3062b5c6f6d9275